Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Sutro Biopharma, Inc. (STRO) vs Zentalis Pharmaceuticals, Inc. (ZNTL)

Sutro Biopharma, Inc. and Zentalis Pharmaceuticals, Inc. are both Biotechnology companies. Sutro Biopharma, Inc. and Zentalis Pharmaceuticals, Inc. are of similar size ($260.5M and $260.4M). Zentalis Pharmaceuticals, Inc. has the higher net margin (0.00% vs −395.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Zentalis Pharmaceuticals, Inc. leads on 6 and Sutro Biopharma, Inc. on 5.

Valuation

Metric STRO ZNTL Biotechnology median
P/E n/m n/m 7.88
P/S 5.79 n/m 11.47
P/B n/m 1.34 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 2.83 n/m 10.73
Earnings yield (108.41%) (72.22%) (28.84%)
Free cash flow yield (54.99%) (66.47%) (23.03%)

Profitability

Metric STRO ZNTL Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (319.57%) 0.00% 0.00%
Net margin (395.25%) 0.00% 0.00%
Free cash flow margin (318.63%) 0.00% 0.00%
Return on equity 266.76% (66.75%) (57.72%)
Return on assets (79.08%) (49.22%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric STRO ZNTL Biotechnology median
Revenue growth (TTM) (56.25%) — 5.64%
EPS growth (last fiscal year) 24.02% 18.03% —
Revenue growth, 5-year CAGR 19.12% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric STRO ZNTL Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.32 4.82 4.73
Net debt to EBITDA 0.92 1.59 0.96

Dividend

Metric STRO ZNTL Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric STRO ZNTL Biotechnology median
Market cap 260.49m 260.35m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack